Stock EXPRS2 EXPRES2ION BIOTECH HOLDING AB
Add to a list
To use this feature you must be a member
Log inSign up

Consensus ExpreS2ion Biotech Holding AB

Equities

EXPRS2

SE0008348262

Market Closed - Nasdaq Stockholm
Other stock markets
 06:59:32 2024-04-30 am EDT 		5-day change 1st Jan Change
2.545 SEK -2.12% Intraday chart for ExpreS2ion Biotech Holding AB -8.45% +20.62%
Apr. 16 ExpreS2ion Announces Completion of GLP Safety Study for ES2B-C001 (HER2-VLP) Breast Cancer Vaccine Candidate CI
Feb. 21 ExpreS2ion Biotech JV Secures EUR10 Million Following Bavarian Nordic's Completion of COVID-19 Vaccine Trial MT

Evolution of the average Target Price on ExpreS2ion Biotech Holding AB

Price target over the last 5 years

History of analyst recommendation changes

bcfdc.xEsQL871hOu150OgU4gxzWxPfAyzS0e3DD30z21Wz-I.qC5qYqG79ZvfnhL3Br5FhD8JSzrwcizQSWSujgJmt8-HPVRetLHd0teIew~8d82fa7d32343a031116ab39279a3ca2

Analyst Recommendations on ExpreS2ion Biotech Holding AB

ExpreS2ion Biotech : Pareto Securities AS initiates equity research coverage of ExpreS2ion with a Buy rating and target price of 60 SEK per share AQ
ExpreS2ion Biotech : Analysguiden announces new research report with the target price for ExpreS2ion increased to 49 SEK per share AQ
ExpreS2ion Biotech : Analysguiden announces new research report with the target price for ExpreS2ion at 24 SEK per share AQ
ExpreS2ion Biotech : Analysguiden raises its target price for ExpreS2ion to 24 SEK per share AQ
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2.545 SEK
Average target price
9 SEK
Spread / Average Target
+253.63%
High Price Target
9 SEK
Spread / Highest target
+253.63%
Low Price Target
9 SEK
Spread / Lowest Target
+253.63%

Consensus detail

Consensus revision (last 18 months)

Ratings for ExpreS2ion Biotech Holding AB

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. EXPRS2 Stock
  4. Consensus ExpreS2ion Biotech Holding AB